Evaluating Treatment Outcomes Of Intravitreal Aflibercept In Retinopathy Of Prematurity
HITEC Medical and Dental Journal · 30.06.2026
DOI: 10.69884/hmdj.6.1.6853 ↗Kurz gefasst
Fachartikel in der Zeitschrift HITEC Medical and Dental Journal, online erschienen am 30.06.2026. Verfasst von Muhammad Usama Idrees und 5 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Objective: To evaluate the anatomical treatment outcomes of intravitreal aflibercept in infants with severe Stage 3 retinopathy of prematurity (ROP). Study Design: Prospective cohort study. Place and Duration of Study: LRBT Tertiary Teaching Eye hospita , Karachi, 06 months (August 2025 to January 2026). Patients and Methods: This prospective cohort study was conducted at a tertiary care eye hospital. Sixteen infants (32 eyes) with gestational age
Zitieren
APA
Idrees, M. U., Amin, S., Kamil, Z., Ali, A., Khan, M. T. H., & Mehmood, S. (2026). Evaluating Treatment Outcomes Of Intravitreal Aflibercept In Retinopathy Of Prematurity. HITEC Medical and Dental Journal. https://doi.org/10.69884/hmdj.6.1.6853
Vancouver
Idrees MU, Amin S, Kamil Z, Ali A, Khan MTH, Mehmood S. Evaluating Treatment Outcomes Of Intravitreal Aflibercept In Retinopathy Of Prematurity. HITEC Medical and Dental Journal. 2026. doi:10.69884/hmdj.6.1.6853
BibTeX
@article{Idrees2026,
author = {Idrees, Muhammad Usama and Amin, Saima and Kamil, Zeeshan and Ali, Amna and Khan, Muhammad Tanveer Hassan and Mehmood, Sabrina},
title = {Evaluating Treatment Outcomes Of Intravitreal Aflibercept In Retinopathy Of Prematurity},
journal = {HITEC Medical and Dental Journal},
year = {2026},
doi = {10.69884/hmdj.6.1.6853}
}
EUVIMED